| Literature DB >> 7880746 |
S Dorudi1, A M Hanby, R Poulsom, J Northover, I R Hart.
Abstract
A series of colorectal carcinomas (n = 49) resected from patients with known clinical outcomes were analysed for E-cadherin expression using in situ hybridisation to measure mRNA. Patients surviving 5 years or longer (n = 31) exhibited significantly higher levels of E-cadherin mRNA than those surviving less than 5 years (n = 18, P = 0.003). These preliminary results from this small sample suggest that E-cadherin expression may be a useful prognostic marker in colorectal cancer patients.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7880746 PMCID: PMC2033614 DOI: 10.1038/bjc.1995.119
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640